Compare Oscar Health Inc (OSCR) vs Rockwell Automation (ROK) Price & Performance

OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.

Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.

Rockwell Automation (ROK) trades at $432.59, down 2.11% on the day, with a bearish technical signal from moving averages and neutral oscillators. The company shows strong profitability with a 49.09% gross margin and 34.47% ROE, though net income declined to $869M in 2025. Recent news highlights leadership in industrial automation, including partnerships in AI cybersecurity and robotic platforms, supporting positive long-term demand trends.

The stock presents a mixed outlook: analyst consensus targets $489.89 (13% upside) with a majority Hold rating, but high valuation ratios (P/E 40.65) and recent earnings misses pose risks. Key opportunities include automation tailwinds from data centers and labor shortages, while execution on revenue growth and margin stabilization remains critical for shareholder value.